AHG
Akso Health Group
NASDAQ · Financial Services · Financial - Credit Services · CN
$0.85
−2.95%Income statement
| Metric | TTM | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 14.3M | 13.8M | 14.8M | 2.4M | 13.2M |
| Cost of Revenue | 14.8M | 13.8M | 15.1M | 2.3M | 11.9M |
| Gross Profit | (559.9K) | (11.3K) | (281.5K) | 122.1K | 1.3M |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 7.4M | 4.0M | 3.6M | 8.8M | 15.5M |
| General & Admin Expense | 7.4M | 4.0M | 3.6M | 8.6M | 15.5M |
| Selling & Marketing Expense | — | — | — | 168.4K | 6.7K |
| Other Expenses | 94.9M | — | 162.4M | — | — |
| Total Operating Expenses | 102.3M | 4.0M | 166.0M | 8.8M | 15.5M |
| Cost and Expenses | 117.1M | 17.8M | 181.1M | 11.1M | 27.4M |
| Operating Income (EBIT) | (102.9M) | (4.0M) | (166.3M) | (8.6M) | (14.3M) |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | 851.00 | (16.7M) | 34.1K | (453.8K) | 1.2M |
| Non-Operating Income (excl Interest) | (97.9M) | — | (162.4M) | — | — |
| EBT (Pre-Tax Income) | (102.9M) | (20.7M) | (166.3M) | (9.1M) | (13.1M) |
| Income Tax Expense | 12.4M | (2.0M) | (30.8M) | 25.0K | 17.5K |
| Bottom Line | |||||
| Net Income | (95.2M) | (18.7M) | (135.0M) | (9.5M) | (1.4M) |
| Earnings from Cont. Ops | (126.4M) | (18.7M) | (135.5M) | (9.1M) | (13.1M) |
| Earnings from Discont. Ops | — | — | — | (399.8K) | 11.8M |
| Bottom Line Net Income | (95.2M) | (18.7M) | (135.0M) | (9.5M) | (1.4M) |
| Per Share | |||||
| Basic EPS | ($0.26) | ($0.03) | ($0.48) | ($0.45) | ($0.06) |
| Diluted EPS | ($0.27) | ($0.03) | ($0.48) | ($0.39) | ($0.06) |
| Revenue Per Share | $0.02 | $0.02 | $0.05 | $0.12 | $1.73 |
| Shares | |||||
| Basic Shares Outstanding | 722.7M | 722.7M | 285.1M | 20.8M | 7.6M |
| Diluted Shares Outstanding | 722.7M | 722.7M | 285.1M | 23.8M | 7.6M |
| Profitability Metrics | |||||
| EBITDA | (2.1M) | (1.6M) | (1.8M) | (8.6M) | (14.3M) |
| D&A | 2.8M | 2.4M | 2.1M | — | 18.4K |
| EBIT | (5.0M) | (4.0M) | (3.9M) | (8.6M) | (14.3M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026